Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Hinterleitner

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk scoreJulia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
EJNMMI Physics|February 5, 2025
Low-activity [<sup>18</sup>F]-somatostatin receptor (SSTR) imaging using [<sup>18</sup>F]SiTATE on a long axial field-of-view PET/CT scannerNils F Trautwein, Eduardo Calderón, Pia M Linder, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
Nature Medicine|February 19, 2022
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature Medicine|April 3, 2019
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2021
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation - development of a risk scoreJulia M Grottenthaler, Annette Konzelmann, Anette Stiegler, et al.
EJNMMI Physics|February 5, 2025
Low-activity [<sup>18</sup>F]-somatostatin receptor (SSTR) imaging using [<sup>18</sup>F]SiTATE on a long axial field-of-view PET/CT scannerNils F Trautwein, Eduardo Calderón, Pia M Linder, et al.
JCO Precision Oncology|September 14, 2020
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment OptionsMichael Bitzer, Leonie Ostermann, Marius Horger, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Nature Cancer|February 5, 2022
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancerRamona Rudalska, Jule Harbig, Marteinn T Snaebjornsson, et al.
Nature Medicine|February 19, 2022
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature Medicine|April 3, 2019
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Pageof 3